186 related articles for article (PubMed ID: 12692106)
1. Complementary medicine use among women enrolled in a genetic testing program.
DiGianni LM; Kim HT; Emmons K; Gelman R; Kalkbrenner KJ; Garber JE
Cancer Epidemiol Biomarkers Prev; 2003 Apr; 12(4):321-6. PubMed ID: 12692106
[TBL] [Abstract][Full Text] [Related]
2. Complementary medicine use before and 1 year following genetic testing for BRCA1/2 mutations.
Digianni LM; Rue M; Emmons K; Garber JE
Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):70-5. PubMed ID: 16434589
[TBL] [Abstract][Full Text] [Related]
3. Complementary and alternative medicine use, spending, and quality of life in early stage breast cancer.
Wyatt G; Sikorskii A; Wills CE; Su H
Nurs Res; 2010; 59(1):58-66. PubMed ID: 20010046
[TBL] [Abstract][Full Text] [Related]
4. Complementary and alternative medicine use by women after completion of allopathic treatment for breast cancer.
Henderson JW; Donatelle RJ
Altern Ther Health Med; 2004; 10(1):52-7. PubMed ID: 14727500
[TBL] [Abstract][Full Text] [Related]
5. Complementary and alternative medicine use is associated with an increased perception of breast cancer risk and death.
Rakovitch E; Pignol JP; Chartier C; Ezer M; Verma S; Dranitsaris G; Clemons M
Breast Cancer Res Treat; 2005 Mar; 90(2):139-48. PubMed ID: 15803360
[TBL] [Abstract][Full Text] [Related]
6. Prevalence, socio-demographic and clinical predictors of post-diagnostic utilisation of different types of complementary and alternative medicine (CAM) in a nationwide cohort of Danish women treated for primary breast cancer.
Pedersen CG; Christensen S; Jensen AB; Zachariae R
Eur J Cancer; 2009 Dec; 45(18):3172-81. PubMed ID: 19811905
[TBL] [Abstract][Full Text] [Related]
7. Patterns of the use of complementary and alternative medicine in women with metastatic cancer.
Yildirim Y
Cancer Nurs; 2010; 33(3):194-200. PubMed ID: 20357652
[TBL] [Abstract][Full Text] [Related]
8. Design and testing of the use of a complementary and alternative therapies survey in women with breast cancer.
Lengacher CA; Bennett MP; Kipp KE; Berarducci A; Cox CE
Oncol Nurs Forum; 2003; 30(5):811-21. PubMed ID: 12949594
[TBL] [Abstract][Full Text] [Related]
9. Behavioral risk factors among women presenting for genetic testing.
Emmons KM; Kalkbrenner KJ; Klar N; Light T; Schneider KA; Garber JE
Cancer Epidemiol Biomarkers Prev; 2000 Jan; 9(1):89-94. PubMed ID: 10667468
[TBL] [Abstract][Full Text] [Related]
10. A test of the self-help model and use of complementary and alternative medicine among Hispanic women during treatment for breast cancer.
Owens B
Oncol Nurs Forum; 2007 Jul; 34(4):E42-50. PubMed ID: 17723972
[TBL] [Abstract][Full Text] [Related]
11. Women's interest in genetic testing for breast cancer risk: the influence of sociodemographics and knowledge.
Bottorff JL; Ratner PA; Balneaves LG; Richardson CG; McCullum M; Hack T; Chalmers K; Buxton J
Cancer Epidemiol Biomarkers Prev; 2002 Jan; 11(1):89-95. PubMed ID: 11815405
[TBL] [Abstract][Full Text] [Related]
12. Knowledge of risk management strategies, and information and risk management preferences of women at increased risk for ovarian cancer.
Tiller K; Meiser B; Gould L; Tucker K; Dudding T; Franklin J; Friedlander M; Andrews L
Psychooncology; 2005 Apr; 14(4):249-61. PubMed ID: 15386771
[TBL] [Abstract][Full Text] [Related]
13. Healthy women with a family history of breast cancer: impact of a tailored genetic counseling intervention on risk perception, knowledge, and menopausal therapy decision making.
Matloff ET; Moyer A; Shannon KM; Niendorf KB; Col NF
J Womens Health (Larchmt); 2006 Sep; 15(7):843-56. PubMed ID: 16999640
[TBL] [Abstract][Full Text] [Related]
14. The use of complementary and alternative medicine among Malay breast cancer survivors.
Shaharudin SH; Sulaiman S; Emran NA; Shahril MR; Hussain SN
Altern Ther Health Med; 2011; 17(1):50-6. PubMed ID: 21614944
[TBL] [Abstract][Full Text] [Related]
15. The role of psychological functioning in the use of complementary and alternative methods among disease-free colorectal cancer survivors: a report from the American Cancer Society's studies of cancer survivors.
Stein KD; Kaw C; Crammer C; Gansler T
Cancer; 2009 Sep; 115(18 Suppl):4397-408. PubMed ID: 19731355
[TBL] [Abstract][Full Text] [Related]
16. The meaning of complementary therapy from the perspective of Thai women with breast cancer.
Sirisupluxana P; Sripichyakan K; Wonghongkul T; Sethabouppha H; Pierce PF
Nurs Health Sci; 2009 Mar; 11(1):64-70. PubMed ID: 19298311
[TBL] [Abstract][Full Text] [Related]
17. Sex differences in motives for use of complementary and alternative medicine among cancer patients.
Hedderson MM; Patterson RE; Neuhouser ML; Schwartz SM; Bowen DJ; Standish LJ; Marshall LM
Altern Ther Health Med; 2004; 10(5):58-64. PubMed ID: 15478787
[TBL] [Abstract][Full Text] [Related]
18. Complementary therapy used by Hispanic women during treatment for breast cancer.
Owens B; Jackson M; Berndt A
J Holist Nurs; 2009 Sep; 27(3):167-76. PubMed ID: 19372389
[TBL] [Abstract][Full Text] [Related]
19. Complementary and alternative medicine use among women with breast cancer.
DiGianni LM; Garber JE; Winer EP
J Clin Oncol; 2002 Sep; 20(18 Suppl):34S-8S. PubMed ID: 12235222
[TBL] [Abstract][Full Text] [Related]
20. Quality of life and complementary and alternative medicine use among cancer patients in Turkey.
Can G; Erol O; Aydiner A; Topuz E
Eur J Oncol Nurs; 2009 Sep; 13(4):287-94. PubMed ID: 19395312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
